Management of side effects of non nifedipine: how to deal with hyperkalemia and hypotension
As a mineralocorticoid receptor antagonist, attention should be paid to the risk of hyperkalemia and hypotension for non nifedipine. The following provides standardized management recommendations in terms of monitoring, dosage adjustment, and drug combination therapy.
Hyperkalemia management
1. Monitoring of high-risk populations
When patients with renal insufficiency, diabetes or ARB/NSAIDs are used together, blood potassium monitoring should be strengthened. At the beginning of treatment, it should be tested weekly until stable. Immediate intervention is required when blood potassium levels exceed 5.5mEq/L.
2. Classification processing measures
Blood potassium levels of 5.5-5.9mEq/L can be reduced and continued with treatment; Administration should be suspended if ≥ 6.0mEq/L. When using CYP3A inhibitors in combination, the dosage should be adjusted to 25mg/day.
3. Taboo drugs
It is prohibited to use potassium supplements, potassium sparing diuretics (spironolactone), and potent CYP3A inhibitors (ketoconazole, etc.) in combination. Symptoms such as muscle weakness and arrhythmia require immediate medical attention.
Hypotension management
1. Preventive measures
The starting dose is 25mg/day, and for elderly or renal insufficiency patients, titration should be done more slowly. Avoid combining with antihypertensive drugs and maintain sufficient hydration during medication.
2. Acute treatment
When symptomatic hypotension occurs, one should lie flat and replenish fluids. In severe cases, medication should be suspended and if necessary, vasopressors should be used to support treatment.
Drug interaction management
1. CYP3A inhibitors
Moderate inhibitors (such as erythromycin) should not be used in combination at a dose exceeding 25mg/day, while potent inhibitors (such as clarithromycin) are absolutely contraindicated.
2. Combination use of NSAIDs
May weaken the blood pressure lowering effect and increase blood potassium. During the combined use, it is necessary to monitor blood pressure and kidney function, especially in the elderly.
Disclaimer：《Management of side effects of non nifedipine: how to deal with hyperkalemia and hypotension》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication！